Quadria Capital Annual report 2020 (final)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Creating
Sustainable
Value
2020 ANNUAL ENVIRONMENTAL & SOCIAL REVIEW
Mission Statement
To help build great companies
by being a preferred strategic
partner and specialized
capital provider across Asia
To become the investor of
choice in Asian healthcare
private equity by generating
superior returns
To create
value while
benefiting the
greater good
of regional
development
About
Quadria Capital
Over
US$2.2 billion
in managed capital
21
Investments
across Asia
Asia’s Leading
Specialist healthcare private equity firm
We are an independent healthcare-focused
private equity firm with assets under
management exceeding US$2.2 billion and
investments in 21 companies across Asia, since
inception. We focus on partnering with promising
regional healthcare companies and helping them
grow into regional leaders through an active and
collaborative investment strategy while
generating outstanding returns for our investors.
At Quadria, we believe that positive investment
returns and constructive social impact can be
mutually inclusive. Hence, we complement our
investment objectives with a progressive
philosophy of creating a positive impact on
environment, society and governance. Our goal is
to empower our companies and the communities
they serve with better healthcare for all.
Content
05
Our Key
Differentiators
09
Quadria’s
commitment to
ESG management
65
ESG Objectives
For 2020
68
Our Stakeholders
07
2020 at a Glance
15
Progress &
Performance Update
67
Quadria Governance
69
Disclaimer
Our Key Differentiators
ESG Annual Report
Our Key
Differentiators
Active Value-Added
Investment Style
“Quasi-strategic” partnership
approach and proven ability to
add tangible value at the strategic
and operational level
Dedicated Operating Partners,
who are senior healthcare
business leaders, focused on
supporting portfolio companies
Deep Healthcare
Expertise
A team with vast operating
and investment experience
in the healthcare sector
Proven ability to harness
healthcare operations and
management expertise to
unlock significant value in
portfolio companies
Strong Network Of
Industry Relationships
Unique capability to leverage local
network to cultivate proprietary deals
at favorable entry valuations
Ability to access global healthcare
companies for attractive business
partnerships and knowledge sharing
with portfolio companies
5 6
2020 at a Glance
ESG Annual Report
Over 20 million
Over 16 million
No. of patients served till date
No. of diagnostic tests run annually
2020
at a glance
We faced one of the greatest health crises of our
generation, one that has shaken the global economy
and disrupted millions of lives and livelihoods. Above
all, this is a humanitarian emergency that calls for
unity and requires each one of us to take
responsibility and to play our part.
As the Co-vid 2019 spread, we, at Quadria Capital,
have collaborated across our portfolio of
healthcare companies to assess the implications
on our businesses, act immediately to address
challenges and help mitigate any risks.
Throughout 2020, we continued to focus on being
a better partner to our portfolios, communities
where we live and work, supporting whatever ways
we can in managing the pandemic. We’re so proud
of our companies and the people, who show up in
countless ways when it counts most. Our
companies emerged stronger and better
positioned for long-term growth and will continue
to create good jobs, support local communities
and, ultimately, secure the future of millions of
people around the world.
Over 240,000
Home health care visits
2.2 millions
Patients served annually
2100+
Hospital beds managed Under
Quadria Network
4,000
Road accident victims
transported free of charge
54000
Doctor and clinical
staff
Over
hrs
Total hours of training annually
The pandemic has had a profound impact globally,
particularly in developing Asia where 70% of the
population live in rural areas with very limited
access to healthcare and an estimated 1 billion
people in the region have never seen a doctor in
their lifetimes. If the current crisis has taught us
anything, it is the understanding of what the
healthcare industry must deliver today - namely,
high quality, affordable healthcare for all. Healthcare
must be available, accessible and affordable for all.
We must build sustainable businesses that can
stand the test of time. It is aligned with Quadria
Capital’s purpose: invest in quality healthcare
businesses that enhance the quality of life and
contribute to a healthier future.
We are working with our internal teams and
external experts to ensure that Quadria stays
competitive and compelling in a most responsible
and impactful way far into the future.
Focusing on social good, Quadria’s portfolio
companies exhibit strong financial performance
while also creating positive social impact on the
communities they serve. Through Quadria’s
investments, our portfolio companies further our
shared vision of increasing affordability and
access to high quality healthcare services and
products for those who need it most..
Over 22,000
employees
50%
Female employees
Social Impact
25%
Below peer pricing in select hopitals
Over
Covid patients treated
Focusing on social good, Quadria’s portfolio companies exhibit strong financial performance
while also creating positive social impact on the communities they serve. Through Quadria’s
investments, our portfolio companies further our shared vision of increasing affordability and
access to high quality healthcare services and products for those who need it most.
7 8
Quadria’s
Commitment to
ESG Management
Robust ESG principles
At Quadria, we have built strong principles that act as
foundations for our ESG practices. Our ESG principles
are based on our thoughtful core values centred
around creating sustainable value.
Approach
Robust ESG principles
Creating Sustainable Value
Integrity
Create and implement a culture of
highest ethical standards across
Quadria and partner companies.
Quadria’s commitment to ESG management
Quadria’s Health Impact Circle
Quadria has developed a clear and tangible
approach to profile investments for their
potential to generate impact. Intrinsic to this
approach is the idea of value creation:
developing and implementing solutions that
create value for the target communities.
Fundamental to our idea of impactful healthcare
are the following four dimensions represented
through the Quadria Health Impact Circle.
Aligning to this approach, we screen investment
opportunities for their potential to increase
access to high quality and affordable healthcare
while generating awareness about preventive
health measures and healthy living in the
communities they serve.
ESG Annual Report
Teamwork
Collaborate across geographies and
departments to produce cross
functional insights for maximum
impact.
Accountability
Establish a culture of responsibility
and accountability through annual
reporting on key accomplishments.
Integrating ESG and Impact Considerations
Throughout The Investment Process
At Quadria, impact is not a secondary consideration or an afterthought in the investment decision.
The intent to generate sustainable impact must be internal and present at every stage of planning
and execution. In the investment process, the impact intent is an inherent consideration right from the
initial screening till the time of exit.
Quadria follows a detailed environmental and social policy to track and address ESG and create positive
impact across the entire investment life cycle
Innovation
Driving thought leadership on social
and environmental issues across the
region and communities.
Relationship Driven
Foster meaningful everlasting
relationships with all stakeholders to
create value.
Pre-Investment
Screen
Identify scalable
business models that
can generate attractive
financial returns by
serving mass markets
Screening for
excluded activities
Identify entrepreneurs
with shared vision of
fostering a mutually
beneficial relationship
with the community
Due Diligence
Use specialist advisors
for comprehensive ESG
diligence
Draft an ESG action plan
for strengthening ESG
aspects
Engage with Limited
Partners to align ESG
and Impact objectives
from the investment
Documentation
Include ESG action plan
in transaction documents
to secure investee’s
commitment towards
implementation
Monitoring and
Reporting
Ensure trainings
for investee staff
Ensure ESG compliance
via reporting at Board
level and annual
performance evaluation
Regular tracking
and reporting
Excellence
Develop a culture of excellence and
promote best practices across key
functional areas.
Quadria has inhouse ESG Resource and requires each portfolio company to designate ESG Manager to
ensure comprehensive ESG management throughout the life of the investment
12
Quadria’s commitment to ESG management
ESG Annual Report
A Systematic Process
Environmental
Impact
Access
As part of Quadria’s Sustainability and ESG
Program, partner companies are asked to:
< 1 Bed/1000
People
as against
5 Beds
recommended by WHO
Over
2.6 Billion
people live below
$3 per day
Establish ESG policies and goals.
Participate in the Quadria Sustainability
Initiative and ESG Council.
Complete an Annual Sustainability and ESG
Performance Self-Assessment, Framework
Analysis and commit to an ESAP.
Governance
Impact
Social
Impact
< 1 Doctor/1000
People
as against global average of
3 Doctors
Out-of-pocket
healthcare
expenditure
key driver for poverty
Measure and report on the progress of their
goals and action plans.
Environmental Impact
Efficient use of natural resources
Recycling and re-use for preservation
Reduce negative footprint by checking all types of pollution
Awareness
Quality
Environmental,
Social Action Plan
Responsible waste disposal
No use of hazardous materials
Governance Impact
About
70%
of Asia’s population
lives in rural areas
Diverse and
fragment private
sector results in
low quality
We incorporate responsibility and sustainability
aspects into our investment thesis, thereafter
ensuring that sufficient resources are channelled
into our portfolio companies so as to realise the
objectives of our ESG initiatives.
Transparency, ethics and integrity
Check on corruption and money laundering
Strengthened compliance and reporting via Board
and Committees
Internal controls
Requisite approvals and licenses
In Indonesia, over
60%
of diabetics are
undiagoned
Informal providers
make up a major
portion of
healthcare in India,
as high as
65%
Our ESG objectives are aligned through an
Environmental and Social Action Plan which is
developed post-investment that outlines our goals in
producing tangible environmental, health, safety
and social outcomes.
Social Impact
Increased access and affordability
Serving the underprivileged Strengthened compliance and
reporting via Board and Committees
Community service initiatives Requisite
approvals and licenses
in certain states
Employment generation
Gender equality
Labor laws and employee welfare
13 14
Progress &
Performance
Update
Progress & Performance Update : Lablink
ESG Annual Report
Lablink
Investment Date Mar 2018
Country
Malaysia
Sector
Life Sciences
Focus
Pathology Service
Provider
Website
www.kpjlablink.com
Date period (Jan-Dec 2020)
0.28 millions
Number of COVID tests
conducted
68%
Proportion of female
employees
56
No. of new jobs
15.9 million
Test conducted
Overview
Lablink is Malaysia’s leading diagnostic service provider and subsidiary
of Malaysia’s leading private healthcare provider KPJ Healthcare
Berhad. Headquartered in Kuala Lumpur, Lablink currently provides
diagnostic services to the KPJ Group of hospitals, other healthcare
providers as well as directly to customers in Malaysia. With over 500
service staff, Lablink offers high quality diagnostic services through the
operations of its central laboratory and 29 branch laboratories.
Lablink operates in a market supported by strong tailwinds. Demand for
diagnostic services, now noticeably exacerbated by the recent COVID
pandemic has been rising rapidly across Southeast Asia with growing
health awareness and increase in disposable income. At the same time,
the proliferation of small- to mid-sized hospitals created demand for
outsourcing laboratory management to independent laboratory
providers so as to streamline and optimize cost and operations.
Diagnostics and clinical testing continue to be an integral part of any
healthcare system with the emergence of highly specialized novel
diagnostic techniques and implementation of efficient clinical
workflows.
18,472
No. of hours invested
in training
Quadria’s partnership will help Lablink capture the organic growth of
KPJ Group hospitals, as well as support Lablink’s regional expansion
plan through acquisitions and business partnerships to become the
leader in diagnostics services across Southeast Asia with the objective
of improving the standards of healthcare across the region via export of
expertise from Malaysia, one of the more mature healthcare markets in
Southeast Asia.
17 18
Progress & Performance Update : Lablink
ESG Annual Report
ESG Management
and Compliance
Environmental Impact
Lablink is committed to adopting international
standards and best practices towards achieving its
ESG objectives. Specifically, a thorough assessment
on ESG compliance was conducted prior to
Quadria’s investment in Lablink with the objective
of identifying gaps in the current practice and
developing a roadmap leading to higher levels of
compliance. The result is a concrete plan to improve
the company’s environmental and social policy, as
well as corporate governance standards.
The plan has almost been fully implemented thus
far and forms an explicit target of the CEO and
senior management while employees are
continuously educated about and made aware of
the importance of adhering to the requisite ESG
standard.
Further, dedicated personnel have been tasked with
the responsibility of overseeing the implementation
of agreed ESG initiatives. At the board level, there is
continuous monitoring of management’s efforts in
upgrading its controls, procedures, policies and
systems that to ensure systematic integration of
ESG considerations in all aspects of Lablink’s
operations. The Company has not reported any
serious ESG incidents for the reporting year and
continues to be in compliance with applicable laws
and regulations. Lablink is certified for ISO
9001:2015 and accredited for MS 15189:2014. Most
distinctively, Lablink Central is the first private
laboratory in Malaysia to comply with the
Bio-Safety Level 3 (BSL3) Laboratory for testing of
highly infectious diseases.
Lablink assesses and evaluates its environmental
risks and includes it in HIRARC documents which is
reviewed annually. It has established two
environmental related committees to oversee
environmental legal compliance
(ERCMC-Environmental Regulatory Compliance
Monitoring Committee) and (EPMC-Environmental
Performance Monitoring Committee) for operational
performance related issues.
Improved waste management for fluid clinical
waste from the analyser
Improved labelling of all Scheduled Wastes store
as per DOE guidelines
Increased Clinical Waste collection frequency
Disposal of e-waste to prescribed premises
On the health and Safety front, Lablink has
adopted following initiatives
Deployed Teams for OSH committee
workplace Inspection
LEV upgrading for haematology and RBC
new system.
Monitoring hazard identified during workplace
inspection (3-monthly) and rectification
within 3 months.
Training provision for staff on Psychosocial
Hazard Management at Workplace
Conduct Excessive Noise Identification
(by Safety & Health Officer) and Noise Risk
Assessment
Implemented strict protocols for infectious clinical
waste (COVID19 waste) disposal to prescribed
premise
Development of new SOPs such as Guidelines
for HIV, HEP B, HCV exposure post prophylaxis
recommendation
Recycle activities for items which are recyclable
such as box and plastics.
Conducted Occupation Safety & Health
Workplace Assessment-OSHWA 2020 as
per instructions by DOSH and rated as
‘’A-Excellent”
19 20
Progress & Performance Update : Lablink
ESG Annual Report
Social Impact
Lablink conducted 15.9 million diagnostic tests during the reporting period. Lablink established itself as a
leading center for COVID-19 testing and continues to work closely with the Malaysian authorities to manage
growing test demands Lablink conducted 280k COVID tests during the reporting period.
Within the Company, protocols were laid down to restrict the spread of COVID as well as awareness creation
amongst employees. Some of the measures which were initiated are
Governance Impact
Lablink is led and managed by an experienced management team of professionals and a board of directors
that is committed to ESG impact at all levels of the organization. As part of the KPJ Group listed on the
mainboard of Bursa Malaysia, Lablink has an established governance structure compliant with the listing
requirements and laws of Malaysia. The team is continuing its effort on augmenting its existing governance
structure to enable Lablink to function successfully as an independent organization. In addition to oversight by
the board of directors, working committees have been established under the board and in particular, the
Executive Committee meets periodically to ensure that operational issues are resolved in a timely manner.
Outlook for 2021
Training programs on COVID -19 were held
for all staff
Implementation of social distancing ensured
Provision of essential PPE for staff especially
lab staff involved in Covid-19 testing
Compliance towards Authority requirement on
‘MySejahtera’ for QR code scanning prior entering
to Lablink premise
Carried out frequent sanitation all common areas
with provision of sanitizers
As part of its journey to become a responsible regional leader in diagnostic services, Lablink is relentlessly
pursuing the best ESG practices. Lablink recently developed a set of internal ESG compliance
code and checklist for its employees to adhere to and also introduced training programs to aid with the
implementation. On energy management, the Company proposes to implement the reduction of LEV
(Local Exhaust Ventilation) motor frequency to avoid excessive usage of electricity and noise and also
intends to implement after working hours setback setting for the BSL3 lab to reduce energy use in term
of power and pressure.
Daily monitoring of Employee, Management,
pathologist and outsourced staff temperatures
Employee health status declaration &
monitoring via Google form
Periodic Covid -19 test screening for all staff
involved in Covid-19 sampling and testing
Provision of food, transport and special allowance
for Covid-19 team so as to restrict movement
Development of visitors and suppliers
self-declaration using QR code
Establishment of a coordination team to report on
Covid-19 Urgent & Routine Screening test request
for clients
Job Creation and Employee Training and Development
Lablink currently employs 502 employees of which 68% are women. This represents a 20% growth in the
number of jobs since Quadria’s investment in March 2018. The company continues to impart training for
both its clinical and other staff on various aspects. During the reporting period, 499 employees underwent
training covering 18,000+ hours.
21 22
Progress & Performance Update : Strand Life Sciences
ESG Annual Report
Strand Life Sciences
Investment Date Feb 2018
Country
India
Sector
Life Science
Focus
Specialized diagonstic
company with focus on
next generation
precision medicine
Website
Date period (Jan-Dec 2020)
682,408
Total number of
diagnostic tests
410
Total employees
www.strandls.com
45%
% of women
employees
134
New employees
added
Overview
Every day doctors make difficult decisions while working with imperfect
information. Every one of these decisions is crucial and has an impact on
the quality of life of a patient. That no two individuals presenting with the
same symptoms—and even diagnosed with the same condition—respond
identically to the same therapy, only adds to the complexity. Recognising
the limitations of the current one-size-fits-all approach, healthcare is
rapidly moving towards precision medicine, which uses genetic insights
and advances in technology to provide a deeper understanding of human
physiology. Based on insights from the analysis of large amounts of
clinical data precision medicine can also reduce the cost of treatment by
eliminating ineffective treatment plans. Specialized diagnostic tests have
been increasing rapidly and tests are advised for more than just
identification of infections to becoming an integral part of management
and therapy. Diagnostics vertical has been growing at 15-20 percent
consistently for over a decade. Within diagnostics, specialized diagnostics
market is one of the fastest growing segments and is expected to be over
US$ 700 million by 2022.
Strand Life Sciences as a precision medicine company headquartered in
Bangalore, India is well-positioned to harness this technological
advancement. Strand is a one-point, state-of-the-art solution for cancer
diagnostics, Genomics (Next Generation sequencing based diagnostics)
biomarker and translational research, laboratory services and clinical
research services. It is focussed towards patient care. It has 12 labs spread
across the States of Karnataka, Orissa, West Bengal, Gujarat and
Maharashtra.
23 24
Progress & Performance Update : Strand Life Sciences
ESG Annual Report
ESG Management and Compliance
Strand is committed to compliance with all
applicable laws and regulations and conducting
the business with highest integrity and ethics. The
ESG strategy of the Company aims to develop a
standardized approach, foster continuous
improvement, and ensure a safe and efficient
working environment that minimizes any adverse
environmental and social impact. Strand was the
first company in South Asia to receive CAP (College
of American Pathologists) accreditation for its lab.
Today, Strand has two CAP and NABL (National
Accreditation Board for Labs) accredited labs.
To further strengthen the ESG practices, Quadria
worked with the company to formulate a plan to
strengthen and integrate the system and some of
the developments there were seen in the reporting
year are Policy for employee grievance
management, Policy for retrenchment, awareness
sessions on POSH, inductions for new employees
including contract employees, safety trainings
amongst others. Personnel have been tasked with
the responsibility of overseeing the implementation
of agreed ESG initiatives as well as integrating it
within the processes.
During 2020, Strand divested lab operations (which
was acquired from Quest), which involved transfer
of three labs and associated business along with
200 + employees. Quadria ensured that the
transition was in compliance with ESG
requirements, safeguarding continuity of
employees.
Strand was quick to response to the COVID
situation and was one of the first private labs to get
clearance from authorities to do covid testing. Not
only did Strand put in place a business continuity
plan, it also put in place a COVID 19 action
committee with the responsibility to develop a
master plan, cascading it to all employee groups,
direct and indirect manpower and all facilities,
working with individual facilities to formulate facility
specific plans, ensuring that the entire workforce is
trained and to institute measures to check for
safety compliance.
Environmental, Health and
Safety Risk Management
Driven by the COVID pandemic situation, the focus of the Company was on developing COVID management
policy and training employee on safety practices at the labs. The Company conducted webinar sessions for
awareness of the disease and developed a self-assessment training checklist for prevention of the spread of
COVID 19 for all employees, contract employees, vendor and others visiting the labs.
The Company is committed to compliance with all applicable laws and regulations while conducting business
with integrity and ethics. It has continued with its compliance on waste management operations of its
diagnostics business and efforts on energy conservation. As continuous process of monitoring and
improvement, the company has updated the fire alarm system (FAS) at one its labs in Bangalore and refresher
trainings on safety practices at lab, chemical spill and blood spill management, fire safety and quality
management was imparted to employees.
Social Impact
Strand believes in diversity within its workforce and has more than 400 employees across the country out of
which nearly 45% are female employees. The Company considers that the diversity of the employees and its
inclusive programs contribute to healthy, productive and respectful work environment. With the onset of the
COVID lockdown within the country, Strand focus was on process enhancements and employee facilitation and
wellbeing and several initiatives were undertaken:
Employees processes were enhanced and made
online – Induction, Onboarding, Exit process
Introduction of Special Leaves for employees who
were diagnosed during for COVID-19 at work.
Employees tests were borne by Strand.
HR’s availability to employees’ for support or
guidance during lockdown and post lockdown
COVID special Mediclaim policy at Gurgaon who
were front end for Strand’s first COVID Lab.
Laptops/ Desktops and VPN Accesses provided to
employees who needed to access their systems
from home
Help provided to employees for Govt passes/ letter
of intent along with company organized cab
facilities for easy and safe commute during
lockdown
Employee connects held daily to understand any
areas of concern, well-being, managing work during
lockdown along with engagement activities around
special occasions
Active Communication – Leaders speaking to
employees
25 26
Progress & Performance Update : Strand Life Sciences
ESG Annual Report
Increasing Accessibility of Healthcare
As one of the leading specialized diagnostics company in the country, Strand has been making it easier for our
patients to access critical diagnostic testing over 40 cities.. Strand conducted over 1682,408 in 2020. In addition,
the company provides over 10 proprietary next generation sequencing tests to patients.
Outlook for 2021
Learning and Development
Strand employs rigorous quality systems, including training and competency of professional and technical staff
and internal auditing. In 2020, the company spent over 375 hours in training across various themes ranging
from LEAP scientific session, POSH Policy training, lab safety trainings, fire safety training, session on
performance management, power of habits, crucial conversations, induction for new employees and mental
wellness sessions.
Strand plans further integration of ESG focus within its processes and strengthening ESG implementation
for sustained performance of the Company. One of the initiatives identified for 2021 is implementing
an employee engagement software. Strand will continue its value creation journey by making available
critical and specialized testing at an affordable price to improve overall well-being and health
outcomes.
Governance Impact
The company strengthened its governance mechanism by institutionalizing an Executive Committee,
committee of the Board of Directors, which meets on a monthly basis to discuss operational and compliance
matters. The company has strengthened the process and protocols on Governance through an Audit
committee, Nomination & Remuneration committee and appointed an internal auditor to improve the
effectiveness of the company’s internal control and its corporate governance and accounting processes. The
last Board meeting for the Company was held in December, 2020.
27 28
Progress & Performance Update : FV Hospital
ESG Annual Report
FV Hospital
Investment Date Jul 2017
Country
Ho Chi Minh city, Vietnam
Sector
Healthcare Delivery
Focus
Integrated Regional
Network Spanning
Primary to
Quaternary Care
Website
www.fvhospital.com
Date period (Jan-Dec 2020)
133
Number of new
female employees
69%
% of female employees
6,422
Number of hours
invested in training
222,495
Number of patients
treated
Overview
Vietnam remains one of the fastest growing health care sectors in
ASEAN with economic growth and demographic changes driving the
demand for healthcare services throughout the country. With its
effective containment of COVID-19, Vietnam remains poised to recover
faster from the economic impacts of the pandemic.
FV Hospital continues to play a key role in Vietnam healthcare
infrastructure being the first JCI accredited hospital in South Vietnam
and providing care across more than 30 medical specialties. Currently
the Hospital group has over 1000 employees and caters to quality care
for the local population in and around Ho Chi Minh City and also
receives patients from neighbouring countries of Cambodia, Laos and
Myanmar.
During 2019, FV Hospital achieved the JCI re-accreditation for
2019-2022 with a 99% score on a metric of 1200 measures. This
certificate best recognises FV’s continued commitment to safety and
quality in patient care and hospital management. FV continues to
contribute to the development of Vietnam healthcare by facilitating
the training of local medical talent and raising general health
awareness. With Quadria’s investment and strategic support, FV
intends to keep on improving healthcare affordability, accessibility, and
awareness across Vietnam.
29 30
Progress & Performance Update : FV Hospital
ESG Annual Report
ESG Management
and Compliance
Environmental, Health and
Safety Risk Management
As a leading private healthcare provider in Vietnam, FV is committed to minimize its risks and create positive
and sustainable environmental and social impact. Some of the initiatives adopted by FV during the reporting
year are:
Hospital has signed a contract with Urban Drainage Company for a minor project to upgrade hospital
FV is committed to compliances in its operations, beyond applicable legal and regulatory requirements.
Since 2018, as part of the conditions for Quadria’s investment and partnership, FV took major steps to
integrate environmental, social and governance (“ESG”) considerations into day-to-day management
and operations. FV has inhouse staff for managing EHS, HR and guest relations. FV had also engaged
external ESG advisor to assist with the development of an overarching Environmental & Social Policy
and the putting in place of a comprehensive Environmental & Social Management System, as well as a
corporate governance roadmap. FV persists with its objective to ensure that ESG considerations are
integrated into its decision-making process and to seek continuous improvement to governance.
Wastewater treatment plant (replace equipment and piping) also do the routine maintenance and currently,
the quality of effluent waste water meet the highest level (Class A) of national standard QCVN 28:2010
Organized Fire and Occupational Safety week in November combined with Hospital Fire Drill.
Included OHS training as a mandatory module of FMS Online training program in 2020.
Strictly implemented management process to control risk of waste having potential COVID contamination
element within the hospital.
FV received 100% scoring from DOH on Medical waste management during annual inspection.
FV further continues with its energy efficiency, water and waste management programs.
Social Impact
While private hospitals are not actively involved in treating COVID patient in Vietnam, FV has taken several
initiatives to ensure safety of its front-line healthcare workers, employees, and its patients, including:
Standard Operating Procedures, Protocols and
Guidelines were developed to guide the hospital
staff such as Covid-19 Prevention & Control Policy,
Laboratory Biosafety Guidelines, Instructions for
cleaning and disinfection, handling of infected linen
and of cutlery, and Waste management
Several training campaigns were initiated on
correct usage of PPE and on all control measures to
prevent Covid-19 in the hospital with 961 staffs
joining various training classes related to COVID
Creation of specific forms like nursing assessment,
screening form, health declaration form and others
Online trainings were also conducted for doctors on
medical record completion and system
In addition, FV became the first private hospital in Vietnam to be approved by the MOH to offer CoV -2 RT PCR
testing to patients.
31 32
Progress & Performance Update : FV Hospital
ESG Annual Report
Elevating Standards of Healthcare
For testing activities, since the SARS CoV-2 RT PCR testing was approved on March 28th with the Seegene
system, FV set up a State-of-the-art PCR Lab with unidirectional design that complies with MOH requirements,
with Covid-specific Biosafety guidelines and risk assessment. The lab has 2 dedicated biologists and 5
especially-trained technicians, with capacity to handle 400 samples/day and the Average Turn Around Time
(TAT): 8 – 10 hours.
Outlook for 2021
Affordability and Access
Providing access to world-class healthcare services to Vietnamese patients have been FV’s mission since day
one. Despite COVID challenges, the hospital continues to provide pro-bono treatment to children in the
Children of Vietnam Charitable program, a charity established by FV 10 years ago targeting underprivileged
children. In 2020, the hospital provided free surgeries for 57 children and medical treatments for 101 children
through this fund.
For 2021, FV plans to focus on capacity building of its team on the Quality, Environment and Occupational
Health and Safety aspects and has identified specific training programs for its staff. FV will
continue to be an environmentally and socially responsible healthcare provider and integrate ESG
considerations within its management and operational processes.
Community engagement
During COVID pandemic in 2020, FV implemented strict infection control processes throughout its facilities to
protect staff and patients. A tele-medicine call centre was set up to guide patients to telemedicine services. It
also provided public education and support on COVID through internal and media communication.
Job Creation and Female Empowerment
Job Creation and Female Empowerment: FV currently employs about 1382 employees, out of which 69% of the
total work force are women. More than 80% of the senior management team are women including CFO, COO,
Head of business development. During 2020, about 133 new female employees were hired at FV.
Governance Impact
FV is led by an experienced management with firm commitment to positive social impact including healthcare
accessibility, healthcare technology advancement and employee wellness. Both Quadria and the promoters
area aligned to maintaining the highest standards of governance through regular meeting and
communications between the management team and Board of directors. Four board meetings were held
during the reporting period.
To make sure the welfare of stakeholders is not compromised, FV devotes constant effort in soliciting feedback
from stakeholders on various issues. FV has been engaging with stakeholders in individual meetings, focused
working groups, advisory panels or stakeholder advisory council meetings. On the operational level, the
management team continued to focus on aligning FV’s operations with best-in-class standards set out by the
World Bank and the IFC.
33 34
Progress & Performance Update : Medical Specialists Asia
ESG Annual Report
Medical Specialists
Asia
Investment Date Jun 2017
Country
Singapore
Sector
Associated Healthcare
Services
Focus
Tertiary/Quaternary
Care
Website
Date period (Jan-Dec 2020)
www.shsccentre.com
Overview
For many SEA countries, public healthcare infrastructure is
underdeveloped and medical talent is scarce: the average number of
physicians in SEA is 0.8 per 1,000 people, significantly lower than that in
developed economies such as the UK (2.8), Germany (4.2), and the U.S.
(2.6). Similarly, the same is observed in the number of dentists, nurses
and midwifes.
Over
14,000
Patients served in
2020
80%
Female employees
The vast healthcare demand coupled with the current undersupply of
healthcare services has resulted in immense opportunities for the
private healthcare market to bridge the gap. Leveraging on Singapore’s
reputation for clinical excellence and expertise in Southeast Asia,
Quadria’s investment in Medical Specialists Asia (“MSA”) is driven by the
fundamental objective of democratizing healthcare across Southeast
Asia.
Over
USD 7K
Contributed to community
initiatives
Over 18000
Diagnostic tests run in 2020
MSA is an integrated healthcare provider providing a comprehensive
range of healthcare services including specialist healthcare, general
medical services, day care surgery, diagnostic imaging centre and
aesthetic medical services. The group with a focus on integrating the
latest advances in medicine for prevention, early diagnosis and
treatment of medical conditions adopts a “One Day, One Stop, One
Centre” model.
35 36
Progress & Performance Update : Medical Specialists Asia
ESG Annual Report
ESG Management
and Compliance
Environmental Health and
Safety risk management
MWH is committed to strong compliance practices licenced by both the Singapore Ministry of Health
(MOH) and Singapore Ministry of Manpower. All its staff are aligned towards achieving its ESG objectives
and specific, formal training is integrated into new and existing employee trainings. Workers are also aware
of their targets in relation to social and environmental metrics both as an individual or part of a workplace
team.
To improve its capabilities in complying with the highest environmental, social and governance standards,
apart from assigning responsibilities to in-house staff, MSA management also engages closely with
external consultants to integrate and strengthen ESG aspects in all aspects of it’s operations.
Environmental Efficiency
Measures to ensure energy efficiency and conservation is being deployed, including equipment with built-in
timers as well as layouts to maximise use of natural lighting. Efforts are also being undertaken towards energy
and water efficiency improvements. The Royal Square Novena building, where MSA’s medical facilities are
located was awarded the Platinum Green Mark Award by the Building and Construction Authority (BCA). The
BCA Green Mark award is a green building rating to recognise buildings for its environmental impact and
performance.
Environmental Management
There are requirements imposed on pharmaceutical drug suppliers to disclose specified chemicals of concern
and that they know all the chemical ingredients intentionally added to their product and all residuals of high
concern present in the product. With the available information, an evaluation of products and processes to
identify potential toxic contaminants from production is carried out with the objective of achieving established
metrics and goals for the reduction or elimination of chemicals of concern.
Environment, Health and Safety (HSE)
Indoor environmental quality is monitored to ensure a healthy and comfortable work space. Safety and health
inspections are performed at least quarterly and information discovered through analyses is used to improve
safety processes. Results of these inspections are documented and reports clearly indicate what needs to be
corrected with documented accountability for closure.
Social Impact
Increasing Access to Quality Healthcare
MSA is in talks with several partners across the region to build out centers of excellence, assist in setting up
greenfield hospitals and holding seminars to exchange best practices.
Community Engagement
MSA is active in the fight against COVID and have contributed in areas such as COVID treatment and
management as well as donation in kind of supplies to support running of COVID Recovery Centre for Foreign
Migrant Workers. Doctors have also volunteered their services as part of COVID Surveillance Program at
Foreign Worker dormitories.
37 38
Progress & Performance Update : Medical Specialists Asia
ESG Annual Report
Employee Training and Development
Employees receive paid leave days to allow them to engage in professional development activities. All
employees underwent trainings on various aspects related to Customer Service, Nursing Quality & Skills
Upgrade, Radiographer Quality and Skills Upgrade amounting to total of 500 hours of trainings during the
reporting period.
Governance Impact
Outlook for 2021
As the partnership between MSA and Quadria deepens, greater alignment towards generating positive
ESG impact can be achieved. From the GIIRS rating exercise, MSA has gained in-depth learnings about the
various standards and requirements to abide by the highest ESG standards. With these insights, MSA is
poised to export not just its model of care but also its standards and way of doing business to the rest of
the region.
MSA is led and managed by an experienced management team of professionals and a board of directors that
are committed to ESG impact across all levels of the organization.
An online stakeholder forum exists to provide / report social or environmental concerns or feedback. Meetings
or other engagement mechanisms with local community members and social or environmental advocacy
groups are also carried out.
39 40
Progress & Performance Update : Healthcare at HOME
ESG Annual Report
Healthcare at HOME
Investment Date Mar 2017
Country
India
Sector
Associated Healthcare
Services
Focus
Hom-Based Medical
Care
Website
www.hcah.in
Date period (Jan-Dec 2020)
145,000+
Total home
visits annually
40%
Female employees
400,000
60+
No. of cities
served
26000+
Number of training
hours
Overview
A rapidly ageing population and a rise in incidence of chronic ailments
that require constant monitoring and care, coupled with increasing
disposable income are fuelling the demand for healthcare in India, while
the supply infrastructure is constrained both in terms of quality and
required quantity. Home healthcare is a promising beam of light for
survival and good health of millions by bridging the demand supply gap
while also trying to solve the problem of accessibility and affordability of
healthcare services.
Healthcare at Home is an integrated platform providing healthcare
services to patients at affordable pricing from the convenience of their
homes and is India’s first accredited home healthcare provider after
being awarded the “Mark of Sustained Quality” after clearing Quality
and Accreditation Institute’s (QAI) surveillance audit. Some of the key
medical services offered include setting up ICU at home, providing
Cancer Care at home, nursing care, physiotherapy services and holistic
stroke rehabilitation along with providing plethora of clinical procedures
at home thereby delivering almost 70% of all clinical services at home.
The Company currently provides services in over 60+ cities served over
400,000 patients during 2020 and has partnered with pharmacies
across 50+ locations.
No. of patients served
41 42
Progress & Performance Update : Healthcare at HOME
ESG Annual Report
ESG Management
and Compliance
Environmental, Health and
Safety Risk Management
HCAH is committed to operate in a socially responsible way. It conducts the business fairly and honestly and
recognizes that the long-term health of the organization is directly connected to the health of the
environment and local communities. The company has reported adherence to compliances and no ESG
related incidents for the reporting period.
The company has designed the service protocols to assess, identify and manage occupational health and
safety risks of the employees. Its integrated process safety management systems ensure all existing
processes and new developments are assessed for risk. HCAH continues with its ISO27000 certification for
information security management.
The company operations have limited environmental footprint. The Company has initiated measures of energy
efficiency and continues with it. For waste management, especially bio medical waste management, the
Company has stringent polices on collection and disposal of bio-medical waste and it conducts regular
training of staff to ensure implementation of waste disposal policies.
Social Impact
HCAH’s mission is to improve access to quality healthcare services to the masses by solving the key issue of
demand supply gap in India and it played a key role during the covid times. The Company treated more than
400,000 lakhs patients during Covid, working hand in hand with various state governments, hospitals and
insurance companies to deliver services to patients. It helped in reducing the burden on front line workers by
providing home healthcare services.
Accessibility and Affordability
The Covid pandemic further drove in the importance of home care and HCAH was quick to come up with
solutions and support programs to cater to patients. As the Covid hit, the Company started Covid related
services like home isolation support programs, RT-PCR testing and started working with government for home
monitoring of Covid patients. It also offered solutions for Corporates, their employees resuming operations
during and after lockdown to prevent spread of further Covid cases and enable efficient healthcare services.
In a country where two-thirds of healthcare spending is out of pocket and limited insurance coverage, HCAH is
making high end ICU care, nursing services and drug infusion services accessible to patients at a price points
much lower compared to private hospitals. Home healthcare solutions can be upto 40% less costly as
compared to hospitals. The Company also provides discounts of upto 40% to underserved patients.
Employee Training and Engagement
HCAH believes that its employees are the most important asset to the Company and are essential to maintain
the standards of quality. The Company continuously invests in training and upskilling of its workforce. In 2019,
HCAH introduced upskilling courses for nurses and physiotherapists in association with Fortis Memorial
Research Institute. Additionally, the Company has institutionalized a formal training academy that puts
43 44
Progress & Performance Update : Healthcare at HOME
ESG Annual Report
Governance Impact
Outlook for 2021
HCAH is committed to high ethical standards in its operations and conduct. The Board of Directors consist of
leaders from diverse fields and the Board processes are designed to ensure robust discussion and oversight.
HCAH’s commitment to ethics and compliance at every level of the organization is foundational and
unwavering, it has adopted a Code of Conduct, which applies to every employee, regardless of their level or
position, and lays down the principles that guide our conduct.
The company also has strong internal control processes and has over 70 clinical policies and procedures and
approximately 40 care plans. The polies and care plans are revised every year based on learnings and change
in regulatory environment.
HCAH has formal process to ensure that it complies with all applicable laws and regulation and it continuously
work towards improving the regulation standards, it partnered with Quality & Accreditation Institute (QAI) to
draft and develop the first guidelines for the home healthcare market in India. HCAH is now India’s first
accredited home healthcare accredited by QAI.
The recent COVID situation has created a clear testament of the impact organized home care can create
in the health infrastructure of the country. This impact is expected to strongly sustain in the coming years,
fueled by collaboration of the organized home care players with insurers and hospital chains. HCAH
remains focused on its growth path with integrated ESG requirements for sustained performance of the
Company.
45 46
Progress & Performance Update : Concord Biotech
ESG Annual Report
Concord Biotech
Investment Date Jul 2016
Country
Sector
Focus
Website
India
Life Science
Fermentation Based
Speciality APIs
www.concordbiotech.com
Date period (Jan-Dec 2020)
75+
No. of generic
products offered
13,500+
Products sold in
domestic market
at affordable
pricing
50+
Presence across
emerging markets
14,000
Hours of training
Overview
Concord Biotech is a fully integrated biopharmaceutical
company that develops, manufactures and supplies advanced
life saving biopharmaceuticals for immunosuppressive
conditions, cancer and infectious agents. Concord is a global
leader in the immunosuppressant segment and supplies
between 30-45% of global supplies for some of the largest
immunosuppressants.
Concord is focused on reducing the cost of healthcare,
especially for chronic diseases such as oncology and
immunotherapy Oncology is the largest pharma segment
globally where increase in organ transplantation is driving
demand for Immunosuppressant. Since Quadria’s investment,
Concord has been able to forward integrate into finished
dosage products and has started supplying drugs in the
domestic market and regulated markets.
47 48
Progress & Performance Update : Concord Biotech
ESG Annual Report
ESG Management
and Compliance
For Concord, success extends beyond business to adopting the best global practices in
Environment, Health and Safety. Its comprehensive governance systems are bolstered by best
in class infrastructure, specialized EHS systems and competent teams. Sustainable thinking is
the cornerstone of corporate responsibility at Concord and it has helped in moving beyond
statutory compliances to create responsible business practices that guarantee environmental
sustainability Health and safety are integral parts of a broader environment and the core of the
leadership decision process.
Environmental, Health and
Safety Risk Management
As a responsible corporate organization, Concord has established a best in class environment management
system to minimize its ecological footprint. The focus is on ensuring that environmentally sustainable practices
are incorporated across businesses to create a safe atmosphere for all its employees as well as the community
at large. The EHS Risk Assessment programs methodically detect and evaluate risks on various parameters
ranging from effects on full organization to potential impacts on individual employees. The Risk Assessment
also helps prioritize risks and determine the best way to remove, transfer, or mitigate those risks. Based on this
assessment, Concord defines and documents the EHS roles and responsibilities for all employees at each
operating facility.
Some of the initiatives undertaken by the Company for managing the environmental impact of its operations
include:
Environmental conservation
Concord’s environmental conservation efforts are centered around optimizing energy consumption, reducing
waste and utilizing clean energy in its business operations. Adoption of innovative measures such as energy
efficient centrifugal air compressors, water chillers and motors has enabled it to achieve this objective. The
company recycles the waste water and uses it for external landscaping and other miscellaneous activities.
Waste management also continues to remain a priority for its business and for the planet. Concord has also
adopted best-in-class practices to reduce solid waste during the conversion of raw materials to finished goods
Solid waste generated during production is disposed/ recycled in compliance with applicable environmental laws.
Supplier Guidelines and Procurement Policy
These outline the principles and expectations Concord has set to establish strong business relationships and
ensure that Concord’s EHS and sustainability values are upheld throughout its supply chain. The Procurement
Policy formalizes its sustainable supply chain approach and provides guidance to incorporate sustainable
sourcing principles into its purchasing process.
Emergency Management
Emergency management is a priority for the business to ensure the safety of the community and the
environment. The company conducts regular training and drills to ensure that the all the staff are trained and
aware of protocols in case of an emergency.
49 50
Progress & Performance Update : Concord Biotech
ESG Annual Report
Social Impact
The Company has formally structured its CSR and ESG activities through dedicated teams. The Company
promotes social and economic inclusion for the marginalized communities with its integrated system focusing
across all facets of the communities, especially in healthcare, education, environment and gender equality.
Contribution in fight against COVID
The company has aggressively supported the community in its fight against COVID, by way of setting up of
COVID facility, and distribution of masks and ration kits to the needy. It also ensured that all the employees are
regularly subjected to a medical examination to ensure that medical safety and health of all employees is
maintained.
Governance Impact
Concord is committed to maintaining the highest standards of corporate governance. Quadria believes sound
corporate governance is critical to enhancing and retaining investor trust. Quadria works closely with the
company to attain the best practices in corporate governance as prevalent globally.
Company has implemented several best corporate governance practices to enhance long-term shareholder
value and taken actions to respect minority rights in all its business decisions. The Company’s current policy is
to have an appropriate mix of Executive, Non-Executive and Independent Directors to maintain the independence
of the board and separate its functions of governance and management.
Concord has also been able to maintain a diverse Board that enables efficient functioning through differences
in perspective and skill. The Board had 4 meetings last year, while the ExCo had monthly discussions. Currently,
the Board has three Committees: Audit Committee, Nomination and Remuneration Committee and Corporate
Social Responsibility Committee.
Increasing Affordability of Essential Drugs
Concord has managed to launch a portfolio of over 45 generic finished dosage products in the domestic
market that treat critical illnesses. Concord also plans to increase access to drugs where it manufactures APIs
to other emerging markets. The company has submitted 140 dossiers, cleared 8 audits and has received 4
approvals for emergin markets.
Outlook for 2021
Healthcare Programs
Concord has established a medical mobile program where it provides primary healthcare for the poor, weak
and needy in the surrounding communities. Till date, the company has served over [] patients and served over
6 villages in the surrounding communities. The company has also implemented a dialysis program for poor
patients, where the company is providing free of cost medication and dialysis for patients from economically
poor backgrounds.
Concord remains committed to expanding its ESG related processes and programs, connecting with its
partners, and learning from all stakeholders. Concord and Quadria remain poised to create long term
impact in the region, while adhering to the highest levels of ESG standards. Numerous initiatives have
been implemented as part of its ESAP which will be continuously monitored and maintained.
Education Programs
Concord has initiated various education programs where it is supporting students across various age groups
on their school tuition fee as well as competitive exams for higher education. In 2020, the Company expanded
the education programs to 8 new schools and d started college scholarship program by offering full
scholarships to 2 students from underprivileged background.poor backgrounds.
51 52
Progress & Performance Update : AIG
ESG Annual Report
Asian Institute of
Gastroenterology
Investment Date Nov 2015
Country
India
Sector
Healthcare Delivery
Focus
Gastric Sciences-
Focused Single
Speciality Hospital
Website
www.aigindia.net
Date period (Jan-Dec 2020)
1,200+
New jobs created
191,700
Patients served
Overview
Asian Institute of Gastroenterology (AIG) is a referral centre for gastric health
and is amongst the 20 centres globally recognized as a Centre of Excellence
by the World Gastroenterology Organization – a rare distinction for any
hospital, placing it ahead of many other outstanding medical institutes in the
world. AIG has been successfully creating positive impact by improving the
affordability and accessibility of high quality medical facilities through its
twin-engine business model focused on generating high volumes and driving
process efficiencies.
50%
% of women
employees
5000+
Covid patients
served
AIG’s R&D centre is also recognized as a leading private (not for profit)
research facility in India. In addition to its R&D capabilities, due to its clinical
leadership in gastric sciences, it is the only single specialty hospital worldwide
to partner with Mayo Clinic.
53 54
Progress & Performance Update : AIG
ESG Annual Report
ESG Management
and Compliance
Environmental Health and
Safety risk management
AIG recognizes that to achieve the goals of sustainable growth, the hospital needs to follow conscientious EHS
practices and establish specific objectives and targets to continually reduce its environmental impact and
improve health and safety practices wherever possible.
EHS Management System
AIG is committed to sustainable development and growth, evident in their holistic approach to ESG that
is designed to engage meaningfully with the environment, the people and the wider community. To
manage the E&S aspects associated with its hospital operations, AIG has a dedicated 5-member
quality team lead by Infection Control Officer which oversees the operations and ensure compliance
with highest standards of quality under the supervision and guidance of Medical Director. No serious
ESG related incidents have been reported at the facilities.
In order to strengthen its commitment towards continues quality and risk management, AIG has been
continuously pursuing local and global accreditation. It received the National Accreditation Board for
Hospitals & Healthcare Providers (NABH) accreditation during the last year, which is a public
recognition of the hospital’s standards conferred by an independent external peer assessment of its
performance against prescribed benchmarks.
AIG’s established Policy and a set of internal management and technical standards form the basis of its
Environmental management system. Focus areas are:
Reducing the hospital’s environmental footprint through improvements in systems and procedures
Continuous drive for health and safety management especially fire prevention and security enhancements
Contractor Management: These outline the principles and expectations AIG sets to establish strong business
relationships and ensure that AIG’s EHS and sustainability values are upheld throughout its’ supply chain
Infection Control: AIG also strengthened infection control committees, which regularly hold meetings to
institutionalize the process that help reduce infection among patients
Waste Management
AIG had established waste management procedures, with an aim of reducing the adverse impact of waste
generated on the environment and safe handling of hazardous waste generated. During 2019, AIG constantly
monitored and measured environmental inputs and outputs in a context-based manner including water, solid
wastes and greenhouse gases, with clear reduction targets.
The Company has implemented a zero-waste water discharge policy. The entire waste water generated at the
new facility is treated at the STP and recycled for use in landscaping, washing of external areas, etc.
AIG has obtained all the required licenses for bio-medical, radioactive and other hazardous waste disposal and
is complaint with all the applicable legal requirements.
Also, the company at one of its facility extended and renovated the biomedical waste storage room as per
revised NABH guidelines. During the year, the company discharged 200,561 kg of biomedical waste.
Energy Conservation
AIG has implemented a building management system that allows the company to manage and conserve
electricity at the facility. Some of the initiatives implemented during the year include:
Usage of recycled water for cooling tower resulting in saving of ~70 kl per day
Usage of solar panel and Grunfoss system for hot water supply instead of diesel fed hot water generator
Changing of temperature of chiller set as per the weather variation to save electricity
55 56
Progress & Performance Update : AIG
ESG Annual Report
Social Impact
AIG is well-recognized for its quality and affordable medical services in gastroenterology and has successfully
created immense social impact. With its leading clinical expertise, over 50% of its patients are referral patients.
As many of these patients are unable to afford medical care, AIG ensures that medical needs are met by
offering free treatment and hospital stays for patients from low-income groups. Patient cross-subsidy is
carefully implemented to ensure accessibility to all income classes, ensuring prices are kept 20% to 30% lower
than other hospitals in the region.
Governance Impact
AIG is committed to promoting fundamental values of honesty, integrity, and ethical conduct among all
stakeholders. AIG undertakes a wide variety of steps to keep informed employees informed about current and
proposed laws, regulations, and guidelines
AIG is committed to promoting fundamental values of honesty, integrity, and ethical conduct among all
stakeholders. AIG undertakes a wide variety of steps to keep informed employees informed about current and
proposed laws, regulations, and guidelines
Meaningful contribution in fight against COVID
During this crisis, AIG provided strong staff support and engagement. Staff numbers were maintained to cope
with increased COVID-19 related workload and COVID management trainings were imparted. Company put in
place welfare measures for all frontline staff who attended to COVID related matters with proper rotation of
duties/leave compensation and additional incentives. A dedicated quarantine facility was established and
managed exclusively for AIG staff who got exposure to infection and needed to stay home to prevent the
exposure to their families/community. All the staff and their immediate families (symptomatic or a
symptomatic) were treated free of cost at the hospital who shared the risk of being exposed at the hospital
while managing / treating patients.
Following government guidelines and advisories, AIG also instituted health safety measures within its facilities,
with a dedicated wing for its COVID-19 patients, and reserved isolation wards for staff with COVID symptoms.
AIG has successfully treated more than [5000 COVID patients so far.
Job Creation and Training
The Executive Committee meetings were held on a monthly basis in 2020, to discuss the business performance
and other growth initiatives. AIG also has robust board that enables efficient functioning through differences in
perspective and skill, the Board had 4 meetings last year
Some of the initiatives adopted in 2020 were employee grievance mechanism, incident reporting mechanisms
were made online through AIG portal and employees were educated about updates through sessions and
training videos
Outlook for 2021
AIG remains well-positioned to drive significant, scalable developmental impact in the region. Over the
next one year, AIG plans to scale up the operations and enhance patient services by further adding
comprehensive Master Health Check and COE’s for additional specialties including Neurology, Neurosurgery,
ENT, Orthopedics and Emergency & Trauma center with continued compliance of all local and
national laws. The company is working towards JCI accreditation by end of 2021, signifying AIG’s compliance
to global best practices of health care quality of care and patient safety. AIG is also targeting to
achieve complete lab NABL certifications by June, 2021.
AIG currently employs about 3594 employees and women make-up about 50 percent of the total work force. It
is committed to fostering and supporting diversity and has focused on the representation of women and
minorities in management. The Company also works towards improving the skill set of the employees and
imparted training of ~1,300 hours to employees during 2020.
Education and Learning
AIG contributes towards improving the healthcare supply infrastructure by offering a structured teaching and
training programs in gastric disciplines leading to the award of DNB and PhD degree Each year, the hospital
trains 20 doctors and awards 12 DNB degrees 5 PhD degrees. Additional DNB seats (4 per specialty) has been
57 58
Progress & Performance Update : Medica
ESG Annual Report
Medica
Investment Date Dec 2013
Country
Sector
Focus
Website
India
Healthcare Delivery
Multi-Speciality
Tertiary and
Secondary Services
www.medicahospitals.in
Date period (Jan-Dec 2020)
57%
% of female
employees
255,362
Total patients
treated
40,000
Training hours
850
5880
Covid patients
treated
Operating bed
capacity
Overview
India’s Eastern states, which with a population of ca. 350 million inhabitants make
up roughly 25% of India’s total population, face a still more adverse healthcare
context than the country as a whole. Both public and private healthcare provision
and infrastructure in these states lacks behind the country’s averages. The
Eastern states have 0.45 hospital beds per 1000 inhabitants, considerably below
the Indian average of 0.66 beds per 1000 inhabitants. Especially in the smaller
northern states, the great majority of the provided hospital beds cluster in the
urban centres with very little to no provision in rural settings.
Medica provides affordable healthcare services in the highly underserved region
of Eastern India. It operates with the bed capacity of 850 beds across 5 hospitals
in four cities of Eastern India and is the only player offering some of the advanced
high demand services in that part of the country. With Quadria’s investment,
Medica has commenced new hospitals, adding over 500 beds. Quadria has
helped the Company in identifying the hospital locations in non-metro cities with
high unmet demand and facilitated partnerships in those regions. The Company
continues to focus on providing affordable healthcare to low and middle income
patients by pricing the services at ~15-20% discount vis-à-vis its peers and
allocating low price beds in all its hospitals.
A study on “The Role of Private Healthcare: An East Indian Case Study” into
Medica by consultancy Syspons, Germany commissioned by Quadria’s LP,
Swedfund International AB, highlighted relevance of Medica’s role in meeting the
substantial delivery gaps of the healthcare sector in Eastern India which cannot
be filled by the public sector alone. Medica has managed to substantially grow its
revenue and achieve profitability while offering affordable quality healthcare. The
group’s hub and spoke model, with a superspecialist hospital in Kolkata and
specialist hospitals in tier II and tier III cities, contributes to the viability of the
business and to improved access to healthcare for underserved communities.
59 60
Progress & Performance Update : Medica
ESG Annual Report
ESG Management
and Compliance
Environmental, Health and
Safety Risk Management
Quadria has been working closely with the company to ensure development, implementation and monitoring of
ESG metrics across all the units of the company. The Company has reported adherence to applicable ESG
compliances and had no ESG related incidents during the reporting period. Medica has implemented
Environmental and Social management systems across majority of its hospitals which outlines the company’s
commitment to identifying, assessing, and managing environmental and social risk management; defines the
decision-making process, describes the roles, responsibilities and capacity needs of staff for doing so and
states the documentation and recordkeeping requirements. Medica complies with the highest levels of quality
standards, which reflects in the quality accreditations received by its units:
Medica’s Kolkata, Ranchi and Siliguri are NABH accredited hospitals and Kolkata and Ranchi also have NABL
accreditation.
All units of Medica maintains adequate manpower in all departments to avoid issues of overtime, the
management ensures implementation of minimum wages at group level including all hospitals. All cases
pertaining on labour law matters are duly monitored at regional HR head level and immediate escalation is
being initiated if any reported. Medica also puts great emphasis on maintaining healthy working conditions for
the employees and continuously monitors areas like emergency safety, electrical prevention, chemical
prevention, sickness and long term disease prevention etc. Medica ensures staff awareness at all levels and has
provided for grievance mechanism at all unit. Introduction and induction training is an integral part for any new
joiners; compliance of the same has been further strengthened.
Company’s environmental efforts focus waste management, natural resource, and energy consumption.
Waste Management
Medica has devised and implemented stringent waste management practices across all its hospitals, through
which it has ensured that the bio medical wastes are segregated and proper care is taken while collecting and
disposing it. Also, Waste collection and handling is duly monitored at Unit Level and with proper documentation
and handed over to authorized agencies for proper disposal.
Natural Resource and Energy Consumption
To utilize rainwater and reduce wastage of water, Medica has implemented a rain water harvesting system at
some of its hospitals. The Company has ongoing practices to improve the efficiency of electricity and water
usage. Medica uses its own generators that produce oxygen from the air. This allows the corporation to reduce
CO2 emissions and energy usage, especially in more rural areas, as the gas doesn’t have to be transported in
bottles, over land. Piloted at the group’s Ranchi hospital, the oxygen generator already reduces the group’s CO2
footprint, by saving energy and being more cost efficient. The hospital group also maintains a greenhouse gas
inventory, based on the amount of electricity consumed at its facilities for instance by the various air condition
appliances and medical equipment. The inventory aids to calculate the total CO2 emittances of the different
appliances and equipment and so enables the group to understand its emitted amount of greenhouse gas. Due
to such activities, Medica was recognized with the ‘Green Operation Theatre’ certificate by Bureau Veritas, as
one of the first hospitals in the region to receive the environmental accreditation.
Social Impact
During the COVID, Medica was affiliated as a referral COVID treatment Hospital and played a key role in serving
Covid patients. Medica carried out over 500 tests daily for COVID detection and treated 5880 COVID patients.
Quadria worked along with a couple of DFIs LPs and facilitated over a million dollar grant for the Medica group
hospitals for COVID management for its employees and patients such as PPE procurement, infrastructure
changes for isolation centers and others.
Accessibility and affordability
Medica served 255362 patients in 2020. The majority of the group’s patients belong to the middle or upper
socioeconomic classes, who mostly reside in the region’s urban settings. However, around 20% of Medica’s
patients are from East India’s rather underprivileged and poorer segments of society. Medica intentionally aims
to cater to these poorer segments through several policies and CSR activities.
61
62
Progress & Performance Update : Medica
ESG Annual Report
Active Participation in Public Insurances Schemes
Medica has earmarked capacity for patients from economically weaker sections that are covered by the
government schemes including Shishu Sathi, Swasthya Sathi, Ayushmaan Bharat and ESI scheme. It treats ~150
patients per month under these schemes.
Free or Discounted Consultations and Surgeries
Medica provides free consultations for the neighbouring communities of its hospitals. These free consultations
are available for all patients residing in a radius of between 3 KM and 5 KM around one of Medica s hospitals.
Medical Assistance in Remote Areas
Medica also provides doctor support in remote areas of Eastern India through medical camps and patient
outposts. Medica organized 125 camps and health talks per annum.
Enhancing Employment Generation
Medica created employment opportunities for local population in Eastern India through its operations
employing 3354 personnel across its hospitals. In 2020, it employed 1375 additional personnel and is also on
forefront of promoting gender equality, with women constituting 58% of its workforce.
Employee welfare and Covid Management
Governance Impact
Medica has successfully implemented robust governance standards to build an environment of transparency
and trust. Quadria has worked closely with the company in ensuring strong level of governance through:
Establishment of strong Board and implementation of Board committees including executive, audit and
nomination and remuneration committees.
Regular meetings are held for Board and committees. In 2018, 4 board meetings were held along with multiple
executive committee meetings
Outlook for 2021
Medica will continue to emphasize on its ESG commitments in 2021 and ensure all the facilities comply with
Quadria’s ESG guidelines. It has planned to be more focused on its audits for all units in 2021.
Medica was quick to deploy initiatives for its employees for Covid management with
Contingency Planning and Assigned"Work from Home,
Conducted Training sessions on awareness of Covid 19, Hand Hygiene, Precautions for Covid 19 and made
modifications in Infection control practices
Arranged Pickups & Drop by the Company for the staff members
Provided accommodation & food at Company Guest House & Company Hostels for staff on covid duties as
well as quarantine facility was made available within hospital premises
63 64
ESG Annual Report
ESG Objectives For 2021
In this ESG Report, we have provided highlights of our Fund’s and portfolio companies ESG and impact performance
from the last year and shared examples of our program outcomes and impacts as part of our
long-standing commitment to
responsible investing and the underlying principles that define who we are as an investment firm.
We achieve these results for our investors by incorporating relevant environmental, social and governance
factors into our investment decision-making process to improve the companies and assets in our portfolio and
make them better places to work. As we move into 2021 as the Economies and our companies emerge out of the
COVID-19, we expect to focus more on
Continuing our engagement with our portfolio companies to strengthen ESG activities within our portfolio
companies
Review and update the fund’s ESG Management system
Training of all fund’s staff on ESG integration aspects
Successfully integrate ESG and impact assessments into all potential investment opportunities presented
to the Investment committee
Participate in the development of tools and research aimed at improving ESG efforts throughout the
private equity sector
We would take this opportunity to thank you for your continued interest in our journey and entrusting your
capital to us with a shared vision to generate sustainable returns, while making a positive impact in Asian
healthcare.
We look forward to continued collaboration in 2021 and beyond.
We welcome your feedback and queries on any of the above matters. We remain committed to serving the best
interests of our Limited Partners. In this ESG Report, we have provided highlights of our Sustainability and ESG
Program activities from the last year and shared examples of our program outcomes and impacts as part of
our long-standing commitment to responsible investing and the underlying principles that define who we are
as an investment firm.
66
Quadria Governance | Our Stakeholders
ESG Annual Report
Quadria Governance
LIMITED PARTNER ADVISORYCOMMITTEE
BUSINESS PRINCIPLES
Our
Stakeholders
The Limited Partner Advisory Committee comprises
representatives of certain Limited Partners and is
responsible for providing overall guidance to the
General Partner and approving decisions relating
to key operational matters of the Fund.
THE BOARD
The Board of Quadria Capital Investment
Managers is responsible for the management and
operation of the Fund. It consists of two Managing
Partners, Abrar Mir and Dr. Amit Varma.
GENERAL PARTNER
Quadria Capital Fund LP is managed by Quadria
Capital GP (“General Partner”). The General Partner
is responsible for decisions related to investments,
divestment and portfolio management. The
General Partner is advised by an appointed
Investment Committee.
INVESTMENT COMMITTEE
The Investment Committee, appointed by the
General Partner, is responsible for advising on
investments, divestment and overall monitoring of
the Funds’ investments. The Investment Committee
comprises Abrar Mir, Dr. Amit Varma, William
Costello and William Fulford.
CONFLICTS OF INTEREST
Quadria Capital has instituted internal policies and
guidelines that seek to reduce and address in a fair
manner, instances of conflicts of interest including
personal account dealings. Every employee is made
aware of the potential for conflicts of interest
expected to arise and is responsible for identifying
and managing such conflicts.
Quadria Capital is committed to maintaining the
highest standards across all our activities. Quadria
Capital has global policies to help ensure prudent
management and operation of the business, with
positive impact on the society, while complying with
applicable laws and regulations.
These policies cover aspects such as risk
management, confidentiality and security,
environmental social governance (ESG), conflicts of
interest, anticorruption and anti-money laundering.
In addition, Quadria Capital has a robust set of
business principles to guide the behavior of all our
professionals and underpin the way we operate. Our
portfolio companies are also made aware of these
principles.
COMPLIANCE
Quadria Capital is regulated by the Monetary
Authority of Singapore. Therefore, compliance with
applicable legislation is mandatory and of prime
importance. The intent and spirit of compliance is
practiced across all areas of business at Quadria
Capital. As a responsible entity, Quadria Capital has
instituted compliance and reporting policies that
cover investments, client dealings, audit, record
keeping, insider trading, personal dealing,
outsourcing, AML, CFT and independence
declarations, amongst other related investment and
management activities. Further, there is an
established protocol for review, escalations and
reporting internally and externally with clear roles
and responsibilities for each team member.
General Partner
Quadria Capital GP
P.O. Box 309
Ugland House
Grand Cayman KY1-1104, Cayman Islands
Investment Manager
Quadria Capital Investment Management Pte. Ltd.
11 A Stanley Street, Level II
Singapore – 068 730
E&S Team
Koel Kumar (ESG head)
Koel.kumar@quadriacapital.com
Rahul Agarwal
Rahul.agarwal@quadriacapital.com
Abhishek Yadav
Abhishek.yadav@quadriacapital.com
Mervin Teo
Mervin.teo@quadriacapital.com
ESG Advisors (2020)
Environmental Resources Management (ERM)
www.erm.com
KPMG
https://home.kpmg/in/
About This Report
This 2020 E&S report demonstrates our progress, our
partners who make this work possible, and lays out our
vision for the future.
67 68
Disclaimer
Disclaimer
The information contained in this Quadria Capital’s
2019 Annual Environmental & Social Review (“Annual
Review”) is given, to the fullest extent allowed by law,
without any liability whatsoever to Quadria Capital,
any of its affiliates or related entities or any of their
respective members, directors, officers or employees
(collectively “Quadria”) for any direct or indirect
losses, damages (including special or consequential
damages), or other costs or expenses whatsoever
arising from any use of, or reliance placed upon, this
presentation or its contents or otherwise.
All content included in this Annual Review, such as
graphics, articles and other materials, is the
property of Quadria Capital or others noted herein
and may be protected by copyright and the laws. All
trademarks and logos displayed in this Annual
Review are the property of their respective owners,
who may or may not be affiliated with our
organization. There can be no assurances that
Quadria’s investment objectives will be achieved or
that our investment programs will be successful.
Investors should read this Annual Review in
conjunction with investment fund quarterly reports,
financial statements and other disclosures
regarding
the valuations and performance of the specific
investments listed herein. No representation or
warranty, express or implied, is made or given by
Quadria as to the accuracy, completeness or
fairness of the information or opinions contained in
this presentation.
Further, certain of the information contained in this
Annual Review represents or is based upon
forward-looking statements or information.
Forward -looking statements are inherently
uncertain, and changing factors, such as those
affecting the markets generally, or those affecting
particular industries or issuers, may cause events
or results to differ from those discussed.
Therefore, undue reliance should not be placed on
such statements or the conclusions drawn
therefrom, which in no event shall be construed as
a guarantee of future performance, results or
courses of action. The information contained in this
Annual Review does not constitute investment,
legal, tax or accounting advice. Recipients of this
Annual Review should conduct their own due
diligence and other enquiries in relation to such
information and consult with their own professional
advisors as to the accuracy and application of the
information contained in this Annual Review and
for advice relating to any legal, tax or accounting
issues relating to a potential investment in the
regions or sectors described. Quadria expressly
disclaims any
obligation or undertaking to update or revise any
such forward -looking statements. References to
portfolio companies are intended to illustrate the
application of Quadria’s investment process only
and should not be viewed as a recommendation of
any particular security or portfolio company. The
information provided about these portfolio
companies is intended to be illustrative, and is not
69
Quadria Capital Investment Management Pte Ltd.
ADDRESS : 11-A, Stanley Street, Singapore 068730
CONTACT : +65 6805 9699
WEBSITE : www.quadriacapital.com
Quadria Capital Advisors Pvt. Ltd
LOCATION : New Delhi, India
ADDRESS : Level 2, The Crescent, Lado Sarai, Mehrauli, New Delhi 110030
PHONE NO. : +91 11 49539900
WEBSITE : www.quadriacapital.com